Myocardial Fibrosis in Dilated Cardiomyopathy

This publication has 11 references indexed in Scilit:

• Progression of Myocardial Fibrosis in Nonischemic DCM and Association With Mortality and Heart Failure Outcomes
  JACC: Cardiovascular Imaging, 2021
• Effects of Danicamtiv, a Novel Cardiac Myosin Activator, in Heart Failure with Reduced Ejection Fraction: Experimental Data and Clinical Results from a Phase 2a Trial
  European Journal of Heart Failure, 2020
• Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy
  Circulation, 2020
• Autophagy Stimulation and Intracellular Sodium Reduction as Mediators of the Cardioprotective Effect of Sodium–Glucose Cotransporter 2 Inhibitors
  European Journal of Heart Failure, 2020
• The Interstitium in the Hypertrophied Heart
  JACC: Cardiovascular Imaging, 2019
• Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
  JACC: Cardiovascular Imaging, 2019
• Myocardial Fibrosis: Biomedical Research from Bench to Bedside
  European Journal of Heart Failure, 2017
• Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
  JACC, 2016
• Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy
  JAMA, 2013
• Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
  New England Journal of Medicine, 2010